510(k) Report

FDA product code · Clinical chemistry

Integrated Continuous Glucose Monitoring System, Factory Calibrated

QBJClass II21 CFR 862.1355510(k) required18 decisions since 20186 recalls

18 FDA decisions since 2018. 510(k) reviews decided 2021–2025 took a median of 119 days (half between 27 and 191). 6 recalls name this code, 1 of them Class I. The most-cited predicate is DEN170088, named by 4 later devices.

An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally…

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical chemistry panel

Twenty years of QBJ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QBJ

2in 2025

2018: 12019: 22020: 12021: 12022: 22023: 42024: 32025: 22026 (partial year): 2
2007high 4 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QBJ

59in 2024

2023: 89 days median2024: 59 days median
2007high 89 (2023) · low 59 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QBJ

4so far in 2026, the most since 2007

2025: 2, 1 Class I2026 (partial year): 4
2007high 4 (2026) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · QBJ

374,651in 2025

2007: 32018: 37,1062019: 80,7742020: 200,7382021: 254,8332022: 232,2882023: 273,5652024: 347,1242025: 374,651
2007high 374,651 (2025) · low 0 (2008)2025

MAUDE reports naming product code QBJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—037,106
20192—080,774
20201—0200,738
20211—0254,833
20222—0232,288
20234890273,565
20243590347,124
20252—2 (1)374,651
20262—4—
FIG. 1 — QBJ by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QBJ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 862.1355.